Iberian Peninsula express shipping
0€ Orders over 60€
*6€ orders under 59€
East, West, South Europe express shipping
0€ Orders over 150€
*18€ orders under 149€
North Europe express shipping
0€ Orders over 160€
*20€ orders under 159€
Ireland, Norway, UK normal shipping
0€ Orders over 60€
*6€ orders under 59€
Rest of the world normal shipping
0€ Orders over 180€
*25€ orders under 179€
Shipping costs can be confirmed in your shopping cart.
For additional shipping methods, please reach out through info@kannabia.com.
Credit card
Bank transfer
Cash on delivery***Website protected by SSL.
**Not available in all regions.
*Your coupon will be sent via email.
*Should you have any question, comment or feedback, please do not hesitate to contact us.
In a study with 880 chronic pain patients treated at several centres in Israel those, who received prescription opioids had higher rates of depression and anxiety than those treated with cannabis. Of all participants 474 received opioids, 329 cannabis and 77 both opioids and cannabis. Depression and anxiety were assessed using the depression module of the Patient Health Questionnaire and the Generalized Anxiety Disorder scale.
Prevalence of depression among patients in the opioid group was 57.1%, in the cannabis group 22.3% and in those receiving both medications 51.4%. Rates of anxiety were 48.4%, 21.5% and 38.7%, respectively. Authors concluded: “levels of depression and anxiety are higher among chronic pain patients receiving prescription opioids compared to those receiving MM [medical marijuana]. Findings should be taken into consideration when deciding on the most appropriate treatment modality for chronic pain, particularly among those at risk for depression and anxiety.”
Source: IACM Bulletin
Kannabia Seeds Company sells to its customers a product collection, a souvenir. We cannot and we shall not give growing advice since our product is not intended for this purpose.
Kannabia accept no responsibility for any illegal use made by third parties of information published. The cultivation of cannabis for personal consumption is an activity subject to legal restrictions that vary from state to state. We recommend consultation of the legislation in force in your country of residence to avoid participation in any illegal activity.
According to a CIS survey of almost 3,000 people in 292 municipalities and 49 provinces of Spain, 84% of Spaniards would legalize cannabis for medicinal purposes. According to this Centre for Sociological Research survey, this…
Scientists have conducted over 140 controlled clinical trials since 1975 assessing the safety and efficacy of whole-plant cannabis or specific cannabinoids, according to a new literature review published in the journal Critical Reviews in Plant Sciences. A pair…
